South Korea's National Cancer Center develops AI platform to predict drug candidate success before clinical trials

South Korea's National Cancer Center is building an AI platform to predict drug success before clinical trials begin. The system will train on cell, organoid, and animal data to flag failing candidates early and cut drug development costs.